[go: up one dir, main page]

HK1189588A - 用於治疗淋巴细胞介导疾病的1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐 - Google Patents

用於治疗淋巴细胞介导疾病的1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐 Download PDF

Info

Publication number
HK1189588A
HK1189588A HK14102684.1A HK14102684A HK1189588A HK 1189588 A HK1189588 A HK 1189588A HK 14102684 A HK14102684 A HK 14102684A HK 1189588 A HK1189588 A HK 1189588A
Authority
HK
Hong Kong
Prior art keywords
ethyl
compound
hemifumarate salt
crystalline form
inhibitor
Prior art date
Application number
HK14102684.1A
Other languages
English (en)
Other versions
HK1189588B (zh
Inventor
Lech Ciszewski
Marilyn De La Cruz
Piotr H. Karpinski
Michael Mutz
Christian Riegert
Caspar Vogel
Ricardo Sschneeberger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1189588A publication Critical patent/HK1189588A/zh
Publication of HK1189588B publication Critical patent/HK1189588B/zh

Links

HK14102684.1A 2008-12-18 2014-03-18 用於治疗淋巴细胞介导疾病的1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐 HK1189588B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US203053P 2008-12-18

Publications (2)

Publication Number Publication Date
HK1189588A true HK1189588A (zh) 2014-06-13
HK1189588B HK1189588B (zh) 2018-01-12

Family

ID=

Similar Documents

Publication Publication Date Title
US20240239743A1 (en) 1-(4-{1-[(e)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylic acid, (e)-but-2-enedioic acid
EP2379499B1 (en) Hydrochloride salt of 1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl)-2-ethyl-benzyl)-azetidine-3-carboxylic acid
EP2379498A1 (en) New polymorphic form of 1- (4- { l- ý (e) -4-cyclohexyl--3-trifluoromethyl-benzyloxyimino¨-ethyl) -2-ethyl-benzy l) -azetidine-3-carboxylic
HK1189588A (zh) 用於治疗淋巴细胞介导疾病的1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐
HK1189588B (zh) 用於治疗淋巴细胞介导疾病的1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐
HK1159631B (zh) 1-(4-{1-[(e)-4-环己基-3-三氟甲基-苄氧基亚氨基]-乙基}-2-乙基-苄基)-氮杂环丁烷-3-甲酸的半富马酸盐
AU2013231122A1 (en) New Salts